Neuroinflammation resolution mechanisms and pro-resolving mediators

Analysis: SDA-2026-04-01-gap-014 | Domain: neurodegeneration | Date: 2026-04-01 | 7 hypotheses | 0 KG edges | Autonomous Agent

Hypotheses

#HypothesisTargetScorePrice
#1 Blood-Brain Barrier SPM Shuttle System TFRC 0.659 $0.66
Engineered transferrin receptor-targeting nanocarriers loaded with stable SPM analogs could bypass the blood-brain barrier's exclusion of endogenous resolvins. This shuttle system would deliver therap...
#2 Senescent Microglia Resolution via Maresins-Senolytics Combination BCL2L1 0.655 $0.66
Combined treatment with maresin analogs plus selective senolytic agents could eliminate senescent microglia while simultaneously activating resolution programs in remaining cells. This dual approach w...
#3 Microglial Efferocytosis Enhancement via GPR32 Superagonists CMKLR1 0.587 $0.59
Synthetic super-agonists of GPR32 (RvD1 receptor) could restore microglial phagocytic capacity for clearing protein aggregates and apoptotic neurons. Enhanced efferocytosis would break the cycle of fa...
#4 Circadian-Gated Maresin Biosynthesis Amplification ALOX12 0.577 $0.58
Chronotherapeutic activation of maresin biosynthesis during natural resolution phases (early morning) could restore circadian inflammation resolution. Time-restricted delivery of MaR1 precursors or AL...
#5 Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution GPR37 0.560 $0.56
Cell-penetrating peptide mimetics of NPD1/PD1 could specifically target oligodendrocytes to resolve myelin-associated inflammation. These mimetics would activate the oligodendrocyte resolution program...
#6 Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Therapy ALOX15 0.554 $0.55
Viral-mediated delivery of ALOX15 specifically to reactive astrocytes could restore endogenous LXA4 biosynthesis. This would reactivate the astrocytic resolution program, converting neurotoxic A1 astr...
#7 Mitochondrial SPM Synthesis Platform Engineering ALOX5 0.458 $0.46
Engineered mitochondria containing optimized SPM biosynthetic machinery could be delivered to microglia via nanoparticles. These 'resolvin factories' would provide sustained local production of pro-re...